Human papillomavirus (HPV) imposes an increased risk of developing cervical, anal and
oropharyngeal cancer. In the Western world, HPV infection is currently the major cause of …

Oropharyngeal cancer (OPC) is currently the most frequent human papillomavirus (HPV)–
related malignancy in high-income countries. Oral HPV16 infection is the cause of HPV …

Background Human papillomavirus (HPV) is a sexually transmitted infection (STI) of global
importance; it is the most prevalent STI in the United States, with strains causally linked to …

The incidence of oropharyngeal cancer (OPC) is significantly increasing in the United
States. Given that these epidemiologic trends are driven by human papillomavirus (HPV) …

Background Human papillomavirus (HPV) vaccines have been used for the prevention of
cervical cancers, and their clinical efficacy has not been well established in the prevention of …

Background Human papillomavirus (HPV) is one of the most common sexually transmitted
infections worldwide. Although the efficacy of the HPV vaccine in preventing the …

Background Although there is evidence that human papillomavirus (HPV) vaccination may
protect against oral HPV infection, no current research has demonstrated this in the general …

Importance Human papillomavirus (HPV) vaccination is recommended for children and
younger adults but not older adults or those with prior HPV exposure, leaving a large portion …

Purpose The incidence of human papilloma virus (HPV)–positive oropharyngeal cancers
has risen rapidly in recent decades among men in the United States. We investigated the US …

Background Human papillomavirus (HPV) infection, particularly with type 16, causes a
growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in …